Abstract:e15147 Background: The Ataxia-telangiectasia mutated (ATM) gene is an oncosuppressor, which plays an important role in the repair of DNA double-strand breaks (DSBs). The mutation profiles of ATM gene in Chinese solid tumor patients can help understand pathogenesis, prognosis, and identify targets for therapy. Methods: Using commercial NGS assays, we retrospectively analyzed genomic DNA alterations in normal-paired samples from 1351 patients with malignancies from January 2021 to October 2022, and alterations including single base substitution, short and long insertion/deletions, copy number variations, gene fusions and rearrangements. Results: ATM gene was altered in 6.8% (92 of 1351) of all solid tumors. The frequency of ATM variations was assessed in multiple cancer types, including non-small cell lung cancer 22% (35/159), endometrial carcinoma 15% (2/13), biliary tract tumor 12.1% (7/58), gastric cancer 10.7% (3/28), prostatic cancer 8.3% (1/12), breast cancer 6.7% (2/30), colorectal cancer 6.5% (11/168), thyroid cancer 6.2% (5/80), cervical carcinoma 5.7% (2/35), prostatic cancer 3.9% (2/51), liver cancer 3% (2/66). A total 102 genetic alterations were identified in 92 patients, including 70 missense mutations (69%), 14 nonsense (14%), 9 splicing (9%), 3 frameshift (3%), 2 deletion (2%), 2 copy number variation (2%). Among these patients, 2 had pathogenic germline ATM heterozygous mutations, including one lung adenocarcinoma and one pancreatic cancer. Furthermore, in our cohort, ATM mutation carriers also owned other actionable mutation, the most frequent one was TP53 (41%), followed by APC (29%), KRAS (23%), MLL3 (22%) and BRCA2 (20%). Conclusions: Our findings indicate that ATM alterations are widely mutated in Chinese multiple cancer types, with specific mutations differing largely among different tumor types. ATM alterations warrant further investigation as predictive biomarkers of response to PARP inhibitors or platinum-based therapy.

Discovery of a Pathogenic Variant Rs139379666 (p. P2974L) in ATM for Breast Cancer Risk in Chinese Populations

Mutation Analysis of the Atm Gene in Two Chinese Patients with Ataxia Telangiectasia

Two-stage case-control study of common ATM gene variants in relation to breast cancer risk

A Pleiotropic ATM Variant (rs1800057 C>G) is Associated with Risk of Multiple Cancers

Prevalence and Characterization of ATM Germline Mutations in Chinese BRCA1/2-negative Breast Cancer Patients

The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis

The association between ATM IVS 22-77 T>C and cancer risk: a meta-analysis

Association Between ATM Rs1801516 Polymorphism and Cancer Susceptibility: a Meta-Analysis Involving 12,879 Cases and 18,054 Controls

The landscape of ATM alteration in Chinese solid tumor patients.

Association between ATM 5557G>A polymorphism and breast cancer risk: a meta-analysis

Ataxia Telangiectasia-Mutated (atm)polymorphisms and Risk of Lung Cancer in a Chinese Population

Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a Chinese Han population.

Association of Genetic Variants in ATR-CHEK1 and ATM-CHEK2 Pathway Genes with Risk of Colorectal Cancer in a Chinese Population.

ATM sequence variants associate with susceptibility to non-small cell lung cancer.

Association of ATM Gene Polymorphism with PTC Metastasis in Female Patients

Functional Polymorphism Rs189037 in the Promoter Region of ATM Gene is Associated with Angiographically Characterized Coronary Stenosis

Single Nucleotide Polymorphism in ATM and Non-Small Cell Lung Cancer Susceptibility

The prevalence of ataxia telangiectasia mutated (ATM) variants in patients with breast cancer patients: a systematic review and meta-analysis

A Whole-Exome Case-Control Association Study to Characterize the Contribution of Rare Coding Variation to Pancreatic Cancer Risk.

The Association of Rs710886 in Lncrna PCAT1 with Bladder Cancer Risk in a Chinese Population.

The Association of CASC16 Variants with Breast Cancer Risk in a Northwest Chinese Female Population